Literature DB >> 25688054

Colorectal cancer. Combining drug therapies to improve treatment efficacy in metastatic colorectal cancer.

Isobel Leake.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25688054     DOI: 10.1038/nrgastro.2015.29

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies.

Authors:  Eugenia R Zanella; Francesco Galimi; Francesco Sassi; Giorgia Migliardi; Francesca Cottino; Simonetta M Leto; Barbara Lupo; Jessica Erriquez; Claudio Isella; Paolo M Comoglio; Enzo Medico; Sabine Tejpar; Eva Budinská; Livio Trusolino; Andrea Bertotti
Journal:  Sci Transl Med       Date:  2015-01-28       Impact factor: 17.956

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.